catalyst

A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symp — primary completion

as of 2026-07-01
at a glance
2015-03 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symp — primary completion
Type
Trial Readout
Date
2015-03
Date type
ACTUAL
Phase
Phase 3
This event happened.